Bebangco, Elliesha Kate A.
HRN: 10-44-55 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2022
CEFUROXIME 750MG (VIAL)
10/17/2022
10/24/2022
IVTT
525mg
Q8h
UTI
Waiting Final Action